Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1 publications
Concurrent radiotherapy and chemotherapy with erlotinib followed by maintenance erlotinib in patients with Epidermal Growth Factor Receptor mutation- positive adenocarcinoma lung.
Journal: JPMA. The Journal of the Pakistan Medical Association
Published: November 20, 2019
Showing 1-1 of 1
Last Updated: 09/26/2026